Lomitapide and high-density lipoprotein function in homozygous familial hypercholesterolaemia

被引：0
|
作者：
Hafiane, Anouar [1 ]
Ronca, Annalisa [1 ]
Incerti, Matteo [1 ]
Rossi, Alessandra [1 ]
Manfredini, Matteo [1 ]
Favari, Elda [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2023年 / 299卷 / 03期
基金：
加拿大健康研究院;
关键词：
D O I：
10.1016/j.jbc.2023.103815
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
1809
引用
收藏
页码：S432 / S432
页数：1
相关论文
共 50 条
  • [41] Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study
    de Boer, Lotte M.
    Reijman, M. Doortje
    Hutten, Barbara A.
    Wiegman, Albert
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (03) : 415 - 419
  • [42] Lomitapide: a novel drug for homozygous familial hypercholesterolemia
    Panno, Maria D.
    Cefalu, Angelo B.
    Averna, Maurizio R.
    CLINICAL LIPIDOLOGY, 2014, 9 (01) : 19 - 32
  • [43] A complicated pregnancy in homozygous familial hypercholesterolaemia treated with lipoprotein apheresis: A case report
    Perrone, Seila
    Perrone, Giuseppina
    Brunelli, Roberto
    Di Giacomo, Serafina
    Galoppi, Paola
    Flammini, Guendalina
    Morozzi, Claudia
    Stefanutti, Claudia
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 113 - 116
  • [44] ABNORMALITIES IN HIGH-DENSITY LIPOPROTEIN COMPOSITION IN FAMILIAL COMBINED HYPERLIPIDEMIA
    BRUNZELL, J
    MAZZONE, T
    MOTULSKY, A
    ALBERS, JJ
    ARTERIOSCLEROSIS, 1982, 2 (05): : A416 - A417
  • [45] The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia
    Van Himbergen, TM
    Van Tits, LJH
    Voorbij, HAM
    De Graaf, J
    Stalenhoef, AFH
    Roest, M
    JOURNAL OF INTERNAL MEDICINE, 2005, 258 (05) : 442 - 449
  • [46] EFFICACY AND SAFETY OF LOMITAPIDE IN PEDIATRIC PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCOLESTEROLEMIA: IS DISCONTINUATION OF LIPOPROTEIN AFHERESIS POSSIBLE?
    Bresolin, A.
    Tosin, P.
    Portinari, C.
    Allegra, M.
    Colpo, A.
    Marin, R.
    Bertocco, S.
    Previato, L.
    Zambon, S.
    Zambon, A.
    ATHEROSCLEROSIS, 2023, 379
  • [47] Statins, high-density lipoprotein, and the low-density lipoprotein/high-density lipoprotein ratio
    Silva, JM
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (05): : 593 - 594
  • [48] High-density lipoprotein. Function and clinical importance [High-density lipoprotein: Funktion und klinische bedeutung]
    Merkel M.
    Der Diabetologe, 2012, 8 (7): : 544 - 549
  • [49] UPTAKE AND DEGRADATION OF HIGH-DENSITY LIPOPROTEIN - COMPARISON OF FIBROBLASTS FROM NORMAL SUBJECTS AND FROM HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIC SUBJECTS
    MILLER, NE
    WEINSTEIN, DB
    STEINBERG, D
    JOURNAL OF LIPID RESEARCH, 1978, 19 (05) : 644 - 653
  • [50] High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein
    Cormode, David P.
    Fisher, Edward A.
    Stroes, Erik S. G.
    Mulder, Willem J. M.
    Fayad, Zahi A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (38) : E3548 - E3548
12345